Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast
Modern Pathology2017Vol. 31(1), pp. 68–82
Citations Over TimeTop 10% of 2017 papers
Marion Lavigne, Emmanuelle Menet, Jean‐Christophe Tille, Marick Laé, Laetitia Fuhrmann, Claire Bonneau, Gabrielle Deniziaut, Samia Melaabi, Charlotte K.Y. Ng, Caterina Marchiò, Roman Rouzier, Ivan Bièche, Anne Vincent‐Salomon
Related Papers
- → GATA3 in Breast Cancer: Tumor Suppressor or Oncogene?(2015)135 cited
- Divergent neuroendocrine differentiation in prostatic carcinoma.(2000)
- → Neuroendocrine Differentiation inthe Precursors of Prostate Cancer(1996)14 cited
- → Bcl11b, a novel GATA3-interacting protein, regulates T-helper-2-cell differentiation and function(2017)2 cited
- The Prognostic Significance of Neuroendocrine Differentiation for Treating Prostatic Carcinoma in 699 Cases of Radical Prostatectomy(2008)